首页 | 本学科首页   官方微博 | 高级检索  
     

CA125、AFP和CEA联合检测在卵巢癌诊断中的应用
引用本文:李庆. CA125、AFP和CEA联合检测在卵巢癌诊断中的应用[J]. 标记免疫分析与临床, 2012, 19(4): 216-218
作者姓名:李庆
作者单位:湖北省荆门市第一人民医院检验科,湖北荆门,448000
摘    要:目的 通过对血清中糖类抗原125 (CA125)、甲胎蛋白(AFP)和癌胚抗原(CEA)的联合检测,提高卵巢癌的诊断率.方法 对58例卵巢癌患者,54例卵巢良性肿瘤患者及对照组118名健康妇女,应用电化学发光免疫法测定血清CA125、AFP与CEA水平,然后进行统计分析.结果 卵巢癌组血清CA125、AFP和CEA水平...

关 键 词:卵巢癌  卵巢良性肿瘤  联合检测

Application of Combined Detection of CA125,AFP and CEA in Ovarian Cancer Diagnosis
LI Qing. Application of Combined Detection of CA125,AFP and CEA in Ovarian Cancer Diagnosis[J]. Labeled Immunoassays and Clinical Medicine, 2012, 19(4): 216-218
Authors:LI Qing
Affiliation:LI Qing (Clinical Laboratory,Jingmen First People's Hospital of Hubei Province,Jingmen 448000,China)
Abstract:Objective To study the clinical values of combined detection of CA125,AFP and CEA in the diagnosis of ovarian cancer.Methods The serum levels CA125,AFP and CEA in 58 ovarian cancer patients,54 ovary benign tumor patients and 118 healthy women were detected.Results The result showed that the serum CA125,AFP and the CEA in patients with ovarian cancer were much higher than that of ovary benign tumor group and normal control group(P0.01).The diagnostic sensitivity of combined detection of three markers was increased than any marker detection alone.Conclusion The combined detection of CA125,AFP and CEA may have important vale in the diagnosis and differential diagnosis of ovarian cancer and ovary benign tumor.
Keywords:Ovarian cancer  Ovary benign tumor  Combined detection
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号